|
GB201602855D0
|
|
Farrerol drug intermediates 2,6-dimethyl-acetanilide synthesis method
|
|
GB201602852D0
|
|
Miconazole drug intermediate 2,4- dichlorophenyl chloromethyl ketone synthesis method
|
|
GB201523191D0
|
|
Card chloride drug intermediates N-chloroacetyl-aniline synthesis method
|
|
GB201523170D0
|
|
Selective methylation agent methyl p- toluenesulfonate synthesis method
|
|
GB201523180D0
|
|
Phenylephrine hydrochloride isoxazole oct drug intermediates o-benzoyl benzoate synthesis method
|
|
GB201523176D0
|
|
Lobenzarit drug intermediates N- o-carboxyphenyl-4-chloro-anthranilic acid synthesis method
|
|
GB201523177D0
|
|
Sodium loxoprofen drug intermediates 1- p-tolyl-2-chloro-1-propanone synthesis method
|
|
GB201523195D0
|
|
Pyrazolone drug intermediates acetyl acetanilide synthesis method
|
|
GB201523186D0
|
|
Thiophene ibuprofen drug intermediates 2- (p-fluorobenzoyl) thiophene synthesis method
|
|
GB201523171D0
|
|
Fenofibrate pharaceutical intermediate 4-chloro-4-hydroxy-benzophenone synthesis method
|
|
GB201523174D0
|
|
Ethyl imidazole drug intermediates acetyl glycine synthesis method
|
|
GB201523189D0
|
|
Celiprolol drug intermediates 3-(4-ethoxyphenyl) -1,1-diethyl-urea synthesis method
|
|
GB201523184D0
|
|
Nisoldipine drug intermediates acetyl isobutyl acetate synthesis method
|
|
GB201523193D0
|
|
Cefalotin drug intermediates 2-acetyl-thiophene systhesis method
|
|
GB201523232D0
|
|
Farrerol drug intermediates 2,6-dimethyl-acetanillide synthesis method
|
|
GB201523196D0
|
|
Methenamine drug intermediates N-benzoyl glycine synthesis method
|
|
GB201523168D0
|
|
Flunarizine drug intermediates 4,4-difluorophenyl ketone synthesis method
|
|
GB201523187D0
|
|
Naproxen drug intermediates 1-(5-chloro-6-methoxy-2-naphthyl) acetone synthesismethod
|
|
GB201523118D0
|
|
Pharmaceutical intermediate 4-amino benzoic acid bromoacetophenone synthesis method
|
|
GB201523115D0
|
|
Tocainide drug intermediates a-bromo-propionyl-2,6-dimethylaniline synthesis method
|
